Gyre Therapeutics's total assets for Q2 2025 were $152.65M, an increase of 17.61% from the previous quarter. GYRE total liabilities were $23.20M for the fiscal quarter, a -8.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.